These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 2836842

  • 1. Effect of mu- and kappa-opioid agonists on the electroconvulsive seizure threshold in mice and antagonism by naloxone and MR 2266.
    Frey HH.
    Pharmacol Toxicol; 1988 Mar; 62(3):150-4. PubMed ID: 2836842
    [Abstract] [Full Text] [Related]

  • 2. Discriminative stimulus effects of mu and kappa opioids in the pigeon: analysis of the effects of full and partial mu and kappa agonists.
    Picker MJ, Dykstra LA.
    J Pharmacol Exp Ther; 1989 May; 249(2):557-66. PubMed ID: 2566680
    [Abstract] [Full Text] [Related]

  • 3. Effect of mu and kappa opioid receptor agonists on rat plasma corticosterone levels.
    Hayes AG, Stewart BR.
    Eur J Pharmacol; 1985 Oct 08; 116(1-2):75-9. PubMed ID: 2996912
    [Abstract] [Full Text] [Related]

  • 4. Opioid kappa receptors and the secretion of prolactin (PRL) and growth hormone (GH) in the rat. I. Effects of opioid kappa receptor agonists bremazocine and U-50,488 on secretion of PRL and GH: comparison with morphine.
    Krulich L, Koenig JI, Conway S, McCann SM, Mayfield MA.
    Neuroendocrinology; 1986 Oct 08; 42(1):75-81. PubMed ID: 3001565
    [Abstract] [Full Text] [Related]

  • 5. Discriminative stimulus properties of U50,488 and morphine: effects of training dose on stimulus substitution patterns produced by mu and kappa opioid agonists.
    Picker MJ, Doty P, Negus SS, Mattox SR, Dykstra LA.
    J Pharmacol Exp Ther; 1990 Jul 08; 254(1):13-22. PubMed ID: 2164087
    [Abstract] [Full Text] [Related]

  • 6. Interactions between the discriminative stimulus effects of mu and kappa opioid agonists in the squirrel monkey.
    Negus SS, Picker MJ, Dykstra LA.
    J Pharmacol Exp Ther; 1991 Jan 08; 256(1):149-58. PubMed ID: 1846412
    [Abstract] [Full Text] [Related]

  • 7. Interactions between mu and kappa opioid agonists in the rat drug discrimination procedure.
    Negus SS, Picker MJ, Dykstra LA.
    Psychopharmacology (Berl); 1990 Jan 08; 102(4):465-73. PubMed ID: 1965748
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. U-50,488, a selective kappa opioid agonist: comparison to other reputed kappa agonists.
    Von Voigtlander PF, Lewis RA.
    Prog Neuropsychopharmacol Biol Psychiatry; 1982 Jan 08; 6(4-6):467-70. PubMed ID: 6298890
    [Abstract] [Full Text] [Related]

  • 11. Spinal antinociceptive actions and naloxone reversibility of intravenous mu- and kappa-opioids in spinalized rats: potency mismatch with values reported for spinal administration.
    Parsons CG, West DC, Headley PM.
    Br J Pharmacol; 1989 Oct 08; 98(2):533-43. PubMed ID: 2555012
    [Abstract] [Full Text] [Related]

  • 12. Further study of kappa opioids on increased urination.
    Leander JD.
    J Pharmacol Exp Ther; 1983 Oct 08; 227(1):35-41. PubMed ID: 6137557
    [Abstract] [Full Text] [Related]

  • 13. Agonist and antagonist activity of kappa opioids in the squirrel monkey: I. Antinociception and urine output.
    Craft RM, Dykstra LA.
    J Pharmacol Exp Ther; 1992 Jan 08; 260(1):327-33. PubMed ID: 1309876
    [Abstract] [Full Text] [Related]

  • 14. Differential antagonism of bremazocine- and U69,593-induced antinociception by quadazocine: further functional evidence of opioid kappa receptor multiplicity in the mouse.
    Horan PJ, de Costa BR, Rice K, Haaseth RC, Hruby VJ, Porreca F.
    J Pharmacol Exp Ther; 1993 Aug 08; 266(2):926-33. PubMed ID: 8394923
    [Abstract] [Full Text] [Related]

  • 15. Orally administered kappa but not mu opiate agonists enhance gastric emptying of a solid canned food meal in dogs.
    Gué M, Fioramonti J, Junien JL, Bueno L.
    J Pharm Pharmacol; 1988 Dec 08; 40(12):873-5. PubMed ID: 2907581
    [Abstract] [Full Text] [Related]

  • 16. Opposite effects of kappa-opioid agonists on gastric emptying of liquids and solids in dogs.
    Gue M, Fioramonti J, Honde C, Pascaud X, Junien JL, Bueno L.
    Gastroenterology; 1988 Oct 08; 95(4):927-31. PubMed ID: 3410236
    [Abstract] [Full Text] [Related]

  • 17. Kappa-opioid agonists do not inhibit adenylate cyclase.
    Makimura M, Murakoshi Y.
    J Pharmacobiodyn; 1989 Mar 08; 12(3):125-31. PubMed ID: 2547926
    [Abstract] [Full Text] [Related]

  • 18. Immunomodulatory activity of mu- and kappa-selective opioid agonists.
    Taub DD, Eisenstein TK, Geller EB, Adler MW, Rogers TJ.
    Proc Natl Acad Sci U S A; 1991 Jan 15; 88(2):360-4. PubMed ID: 1846441
    [Abstract] [Full Text] [Related]

  • 19. Analgesic effect of mu- and kappa-opioid agonists in beige and CXBK mice.
    Muraki T, Oike N, Shibata Y, Nomoto T.
    J Pharm Pharmacol; 1991 Mar 15; 43(3):210-2. PubMed ID: 1675282
    [Abstract] [Full Text] [Related]

  • 20. Effects of intravenous mu and kappa opioid receptor agonists on sensory responses of convergent neurones in the dorsal horn of spinalized rats.
    Dong XW, Parsons CG, Headley PM.
    Br J Pharmacol; 1991 May 15; 103(1):1230-6. PubMed ID: 1652344
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.